ArticleJournal of medical case reports2026
Undifferentiated endometrial carcinoma: a case report.
Article in Journal of medical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundUndifferentiated endometrial carcinoma is a solid tumor that originates from endometrial epithelial cells, accounting for approximately 9% of endometrial cancers. Undifferentiated endometrial carcinoma exhibits high invasiveness, is often diagnosed at an advanced stage, and demonstrates poor sensitivity to chemotherapy. Clinical manifestations lack distinct specificity, with the most common symptoms being abnormal uterine bleeding or discharge and lower abdominal pain. CASE DESCRIPTION: We report the case of a 50-year-old Chinese female individual who was diagnosed with undifferentiated endometrial carcinoma. Surgery was successfully performed; however, on postoperative day 20, she developed fever, dyspnea, pulmonary infection, and renal insufficiency. Computed tomography scan revealed worsening lung metastases and abdominal tumor recurrence. The patient succumbed to respiratory failure on postoperative day 26.
conclusionThe etiology of undifferentiated endometrial carcinoma remains unclear, and its treatment principles align with those for endometrial carcinoma. Patients with early stage disease should undergo staging surgery, while those with advanced-stage disease should follow the surgical approach for ovarian cancer, aiming to remove as much visible tumor tissue as possible. Advanced-stage patients experience rapid disease progression and typically face short-term mortality, with no highly effective treatment options currently available.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.